Segui
Fabio Nascimbeni
Fabio Nascimbeni
Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy
Email verificata su unimore.it
Titolo
Citata da
Citata da
Anno
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and …
S Ballestri, S Zona, G Targher, D Romagnoli, E Baldelli, F Nascimbeni, ...
Journal of gastroenterology and hepatology 31 (5), 936-944, 2016
7202016
Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps
A Lonardo, F Nascimbeni, S Ballestri, DL Fairweather, S Win, TA Than, ...
Hepatology 70 (4), 1457-1469, 2019
6782019
Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?
A Lonardo, F Nascimbeni, A Mantovani, G Targher
Journal of hepatology 68 (2), 335-352, 2018
6402018
NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk
S Ballestri, F Nascimbeni, E Baldelli, A Marrazzo, D Romagnoli, ...
Advances in therapy 34, 1291-1326, 2017
5022017
From NAFLD in clinical practice to answers from guidelines
F Nascimbeni, R Pais, S Bellentani, CP Day, V Ratziu, P Loria, A Lonardo
Journal of hepatology 59 (4), 859-871, 2013
4952013
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
L Fedchuk, F Nascimbeni, R Pais, F Charlotte, C Housset, V Ratziu, ...
Alimentary pharmacology & therapeutics 40 (10), 1209-1222, 2014
4812014
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
A Lonardo, F Nascimbeni, G Targher, M Bernardi, F Bonino, E Bugianesi, ...
Digestive and Liver Disease 49 (5), 471-483, 2017
3102017
Nonalcoholic fatty liver disease: Evolving paradigms
A Lonardo, F Nascimbeni, M Maurantonio, A Marrazzo, L Rinaldi, ...
World journal of gastroenterology 23 (36), 6571, 2017
2362017
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms
LE Adinolfi, R Zampino, L Restivo, A Lonardo, B Guerrera, A Marrone, ...
World journal of gastroenterology: WJG 20 (13), 3410, 2014
1982014
The independent predictors of non‐alcoholic steatohepatitis and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, alanine …
S Ballestri, F Nascimbeni, D Romagnoli, A Lonardo
Hepatology Research 46 (11), 1074-1087, 2016
172*2016
Global multi-stakeholder endorsement of the MAFLD definition
N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ...
The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022
1632022
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology
P Loria, G Marchesini, F Nascimbeni, S Ballestri, M Maurantonio, ...
Atherosclerosis 232 (1), 99-109, 2014
1452014
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases
S Ballestri, F Nascimbeni, E Baldelli, A Marrazzo, D Romagnoli, ...
Metabolism 72, 57-65, 2017
1322017
Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease
F Nascimbeni, J Aron-Wisnewsky, R Pais, J Tordjman, C Poitou, ...
BMJ open gastroenterology 3 (1), e000075, 2016
1312016
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV
A Lonardo, S Ballestri, G Guaraldi, F Nascimbeni, D Romagnoli, S Zona, ...
World journal of gastroenterology 22 (44), 9674, 2016
1292016
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications
S Ballestri, D Romagnoli, F Nascimbeni, G Francica, A Lonardo
Expert review of gastroenterology & hepatology 9 (5), 603-627, 2015
1252015
Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen
A Lonardo, LE Adinolfi, L Restivo, S Ballestri, D Romagnoli, E Baldelli, ...
World journal of gastroenterology: WJG 20 (23), 7089, 2014
1202014
Association between primary hypothyroidism and nonalcoholic fatty liver disease: a systematic review and meta-analysis
A Mantovani, F Nascimbeni, A Lonardo, G Zoppini, E Bonora, ...
Thyroid 28 (10), 1270-1284, 2018
1182018
A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?
A Lonardo, S Lugari, S Ballestri, F Nascimbeni, E Baldelli, M Maurantonio
Acta diabetologica 56 (4), 385-396, 2019
872019
Significant variations in elastometry measurements made within short-term in patients with chronic liver diseases
F Nascimbeni, P Lebray, L Fedchuk, CP Oliveira, MR Alvares-da-Silva, ...
Clinical Gastroenterology and Hepatology 13 (4), 763-771. e6, 2015
812015
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20